November 2, 2023 – Page 3

eXp World Holdings Reports Q3 2023 Results

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

eXp World Holdings Reports Q3 2023 Results eXp World Holdings, Inc., the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises, today announced financial results for the third quarter ended Sept. 30, 2023. Agent Count Grew 5% Compared to Q3 2022 to More Than 89,000 Agents in 24 Global Markets International Realty Revenue Increased 47% Compared to Q3 2022 to an All-Time Record Company Declares Cash Dividend for Q4 2023 of $0.05 per Share of Common Stock BELLINGHAM, Wash., Nov. 02, 2023 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises, today announced financial results for the third quarter ended Sept. 30, 2023. Third Quarter 2023 Consolidated Financial Highlights as Compared to the Same Year-Ago Quarter: Revenue...

QUAINT OAK BANCORP, INC. ANNOUNCES THIRD QUARTER EARNINGS

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

Southampton, PA, Nov. 02, 2023 (GLOBE NEWSWIRE) — Quaint Oak Bancorp, Inc. (the “Company”) (OTCQB: QNTO), the holding company for Quaint Oak Bank (the “Bank”), announced today a net loss for the quarter ended September 30, 2023 of $255,000, or $0.11 per basic and diluted share, compared to net income of $2.6 million, or $1.29 per basic and $1.22 per diluted share for the same period in 2022. Net income for the nine months ended September 30, 2023 was $878,000, or $0.40 per basic and $0.39 per diluted share, compared to $6.7 million, or $3.27 per basic and $3.09 per diluted share for the same period in 2022. Robert T. Strong, President and Chief Executive Officer stated, “The recent actions of the Federal Reserve Bank have exacted a toll on the banking system, such as we have not experienced in modern history. The compression on...

Vital Energy Reports Third-Quarter 2023 Financial and Operating Results

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

Record quarterly production exceeds guidance, leads to increased full-year 2023 outlook Capital investments in quarter were below guidance Publishes 2023 Sustainability Report and inaugural Climate Risk and Resilience Report TULSA, OK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy” or the “Company”) today reported its third-quarter 2023 financial and operating results. Supplemental slides have been posted to the Company’s website and can be found at www.vitalenergy.com. A conference call and webcast is planned for 7:30 a.m. CT, Friday, November 3, 2023. Participation details can be found within this release. Highlights Announced three Permian Basin acquisitions adding a combined 53,000 net acres and 150 gross high-value locations (Maple closed October 31; Henry and...

NL REPORTS THIRD QUARTER 2023 RESULTS

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss attributable to NL stockholders of $.1 million, or nil per share, in the third quarter of 2023 compared to a net loss attributable to NL stockholders of $8.9 million, or $.18 per share, in the third quarter of 2022. NL results include an unrealized gain of $.4 million in the third quarter of 2023 related to the change in value of marketable equity securities compared to an unrealized loss of $24.2 million in the third quarter of 2022. For the first nine months of 2023, NL reported a net loss attributable to NL stockholders of $9.9 million, or $.20 per share, compared to net income attributable to NL stockholders of $39.9 million, or $.82 per share, for the first nine months of 2022. NL results include an unrealized loss of $10.5...

Stryker reports third quarter 2023 operating results

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 billion Organic net sales increased 9.2% Reported operating income margin of 19.0% Adjusted operating income margin(1) increased 110 bps to 23.4% Reported EPS decreased 15.9% to $1.80 Adjusted EPS(1) increased 16.0% to $2.46 Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 10.5 % 0.2 % 10.3 % 0.2 % 10.1 % Orthopaedics and Spine 8.4 0.4 8.0 — 8.0 Total 9.6 % 0.3 % 9.3 % 0.1 % 9.2 % “We...

Apollo Infrastructure Funds Acquire Majority Stake in Modern Aviation

Written by Customer Service on November 2, 2023. Posted in Mergers And Acquisitions.

Tiger Infrastructure Partners and Modern Aviation Management to Reinvest as Part of Transaction NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Apollo (NYSE: APO), Tiger Infrastructure Partners (“Tiger”) and Modern Aviation (the “Company” or “Modern”) today announced that they have entered into a definitive agreement for Apollo-managed infrastructure funds (the “Apollo Funds”) to acquire a majority stake in Modern Aviation, a fixed base operator (FBO) platform serving business and general aviation, as well as commercial, cargo and military aircraft at airports across North America. Tiger Infrastructure Partners, which currently owns Modern Aviation, and the Company’s management team will each reinvest alongside the Apollo Funds. Together, these investments will significantly bolster Modern Aviation’s shareholder base to support future...

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing targeted therapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the third quarter ended September 30, 2023 and provided an update on its corporate activities and product pipeline. “We are proud of the recent advancements of both the REZZAYO program as well as our Cloudbreak® drug-Fc conjugate (DFC) platform,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “The US commercial launch of REZZAYO by our partner Melinta as well as the receipt by our ex-US/ex-Japan partner Mundipharma of the positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...

Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

Initiated a global Phase 2b trial to treat rheumatoid arthritis (RA) with rosnilimab, our PD-1 agonist Initiating in Q4 2023 a global Phase 2 trial to treat ulcerative colitis (UC) with rosnilimab Announced positive top-line Phase 3 clinical trial results of imsidolimab (IL-36R) in generalized pustular psoriasis (GPP) Reiterating cash runway through year-end 2026 and updating expected year-end 2023 cash and investments of $400 to $410 million SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported operating results for the third quarter ended September 30, 2023 and provided a business update. “We’ve made strong progress this quarter executing against our multi-year plan to develop best-in-class...

AMN Healthcare Announces Third Quarter 2023 Results

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97 DALLAS, Nov. 02, 2023 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2023 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q3 2023 % Change Q3 2022 YTD September 30, 2023 % Change YTD September 30, 2022 Revenue $853.5 (25%) $2,971.0 (28%) Gross profit $289.5 (25%) $988.6 (26%) Net income $53.2 (42%) $198.2 (45%) GAAP diluted EPS $1.39 (34%) $4.99 (38%) Adjusted diluted EPS* $1.97 (23%) $6.86 (27%) Adjusted EBITDA* $133.7 (26%) $475.1 (29%) * See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table...

Regency Centers Reports Third Quarter 2023 Results

Written by Customer Service on November 2, 2023. Posted in Earnings Releases And Operating Results.

JACKSONVILLE, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the period ended September 30, 2023 and provided updated 2023 earnings guidance. For the three months ended September 30, 2023 and 2022, Net Income was $0.50 per diluted share and $0.51 per diluted share, respectively. Third Quarter 2023 Highlights Reported Nareit FFO of $1.02 per diluted share, which includes a $0.01 per diluted share impact for merger transition expense, and Core Operating Earnings of $0.97 per diluted share Raised 2023 full year Nareit FFO guidance to a range of $4.13 to $4.15 per diluted share and 2023 full year Core Operating Earnings guidance to a range of $3.93 to $3.95 per diluted share The midpoint of the updated 2023 Core Operating...

Day: November 2, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice